Assessment of electrolyte imbalance and its predictors in children admitted with Acute Gastroenteritis-Cross Sectional study
Abstract
Background: Acute Gastroenteritis is considered to be a major cause of morbidity and mortality among children all around the globe. Annually, 3 to 5 billion cases of Acute Gastroenteritis are reported from all over the world and it is estimated to be responsible for 2 million deaths among children below 5 years of age. Methods: An observational descriptive study with a cross-sectional design was conducted at the pediatric department of North Bengal Medical College and Hospital. The sample size was calculated using the Cochrane formula using the prevalence of the outcome in the population. The patients admitted to the study institution with clinically diagnosed acute gastroenteritis were selected by a consecutive sampling technique till the required sample size was reached. At the time of admission, the sociodemographic details of the patients were obtained from their parents using a predesigned questionnaire. After that, blood was drawn from the patients to measure serum haemoglobin, sodium, potassium, and calcium. Results: Out of 160 children, most of the children were between 49-60 months with male predominance born out of Spontaneous Vaginal Delivery; mothers were young and resided in rural areas. Exclusive breastfeeding was not practised, improper administration or lack of Oral Rehydration Solution contributed to the high prevalence of electrolyte abnormality. Conclusions: The study concludes that there is an urgent need for effective educational interventions to improve…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 160 participants or records.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.